Project Initiation Document

Bio-control of grain storage insect pests

Registering a mycoinsecticide product for use in storage structures.

Project Executive: Julie Flood Senior Users: Dick Shaw

Senior Suppliers:Sean MurphyProject Manager: Bryony Taylor

Date: 12 April 2010

Part A – Background (1)Executive Summary & Objectives

Project Objectives.

•To carry out necessary research work to meet requirements of the registration dossier. •To carry out large-scale trials to this purpose.•To address (e.g. by desk studies) likely concerns of registration authorities.• • • • • •

Executive Summary. The project is to register an experimental mycoinsecticide product to control pests in stored grain. This builds on work done in two LINK projects since 2003 and is a collaboration largely between CABI and FERA and three commercial companies. The project is led by Exosect Ltd

Part A – Background (2)Key Stakeholders and Beneficiaries

● Stakeholders and Beneficiaries:-● Donor: Technology Strategy Board● End-users: Grain producers, storers and processers● Partners: FERA; Exosect Ltd; Sylvan Spawn Ltd;

Connaught.● CABI Centre: Europe-UK Theme - ISM

Part B – Implementation (1)Proposed Organisation Structure

● Corporate Management: Joan Kelley● Project Board:-

● Project Executive: Julie Flood● Senior Users: Dick Shaw● Senior Suppliers: Sean Murphy● CABI Budget-holder: Sean Murphy

Note that, if not the Project Executive, the CABI Budget-holder must have written confirmation from the Project Executive, and the Project Manager if required by Project Executive, prior to authorising payment.

● Project Manager: Bryony Taylor● Team Managers: N/A

Part B – Implementation (2)Stages

StagesWork Packages / Deliverables in Stage, unless indicated in Stage Name

Stage

Completion Date

1) WP1. Improve formulations (CABI led) Month 36

2) WP 2. Non-target effects (FERA and CABI) Month 36

3) WP 3. Chronic and sub-lethal effects (CABI, FERA)

Month 36

4) WP4 Field scale trials (FERA, Exosect, CABI)

Month 36

5) Project management and dissemination Month 36

Part B – Implementation (3)CABI Resource RequirementsStaff(and/or role on project)

Time Required on Project(Indicate whether time is in Days or Months)

Staff required for Business Plan Development (optional): Dave Moore and Belinda Luke

Total time required for Business Plan Development (optional):

Estimate of Cost (£) to complete Business Plan Development Stage (optional):

Remainder of Project (excluding Business Plan Development)

Remainder of Project (excluding Business Plan Development)

Belinda Luke 35 days

Dave Moore 14 days

Bryony Taylor 200 days

Emma Thompson 64 days

Kate Pollard 23 days

Part B – Implementation (4)Customer Acceptance Criteria

The Technology Strategy Board accept that product registration is the objective, but that this objective will be abandoned if either the science or the market suggest that the product will not be successful. Abandonment will be an acceptable outcome.

Part B – Implementation (5)Project Exclusions & Interfaces

Exclusions

No commitment is made to registering a product if the scientific results prove unsatisfactory or if the financial returns are not considered acceptable.

Interfaces● The industrial partners determine the business profitability during the course

of the project.

Part B – Implementation (6)Key Constraints & Assumptions

Constraints● Limited budget.

Assumptions

● Market parameters do not worsen● Timely release of funds● Partners cooperate and remain as functioning organisations● Do not lose skilled staff● Skilled staff are not deliberately removed from project

Part C – Reasons for CABI (1)Key Business Benefits - Strategic

● Expected £133,000 funding for three yr project● The project will result in a product for which CABI will

gain considerable recognition (plus a royalty share).● There would be considerable opportunities to widen the

use of the product, globally● The project will utilise biopesticide experience and help

maintain this expertise within CABI● Strengthening of partnerships (FERA; a biocontrol

company; user and producer)● Assist in further development of Beauveria based

products.

Part C – Reasons for CABI (2)Key Business Benefits – Financial(Externally funded Projects only)

Full Project Budget – Planned Comments

Donor Currency: UK £ From updated PFA January 2013Exchange Rate to £:

Overall Contract Value in £ (if known): £522K (£132,893 to CABI)

Costs Billed to Project Donor (£) £132,893

Gross Revenue (Total Project Revenue): £132,893

Payments to External Collaborators: N/A

Net Income: £132,893

CABI Implementation Costs (£)

CABI Staff Costs: £76,263

Direct Costs:(other direct costs, for example travel, etc)

£12,721

Net Profit/Loss (Project Contribution): £43,848

Net Project Contribution (%): 33.01%

Note that the financials should match the information in the Project Financial Analysis (PFA) form.

Part D – Risks (1)Key Risks(for Collaborator, Security, Technical Risks, see next slides)

Risk Owner Likelihood

(L)

(1=Low;

3=High)

Impact

(I)

(1=Low;

3=High)

Total

(L x I)

(1=Low; 9=High)

Management Strategy

(Choose from Prevention, Reduction, Contingency, Transference, Acceptance, and give brief description of how applied)

Disappointing scientific results

Project manager

1 3 3 Acceptance. Abandon project. Unlikely as earlier projects gave good results; improvements likely

Late availability of funds

Project executive

1 3 3 Prevention. Good project management

Financial viability of product unacceptable

Project management

1 3 3 Acceptance. Abandon project. Dependent on scientific results as market size is acceptable.

Part D – Risks (2)Collaborator Risks

Collaborator Name

(to be paid by CABI)

Has CABI worked with them before? (Yes / No)

Assessment of Collaborator Risk

Include, for example:• Their reputation;• Past experience of working with them (if appropriate).

How much (£) in total is the Collaborator to be paid?

None

Part D – Risks (3)Security Risks

Location of Work Has CABI worked there before?

(Yes / No)

Is there a current, or likely, security risk in that location?

(Yes / No)

Is an alternative secure location eligible for project?

(Yes / No)

UK Yes No N/A

Part D – Risks (4)Technical Risks

Technical Work Has the Lead Centre previously undertaken this Technical work?

(Yes / No)

Has another area of CABI previously undertaken this Technical work?

(Yes / No)

Biopesticide improvement and validation

Yes Yes

Participate in information preparation and dissemination

Yes Yes

Part E – Dissemination & Impact (1)Dissemination of Results

Dissemination Method(what, how, etc)

Target Results Measures

Scientific papers At least one peer reviewed paper Journal paper

Commercial marketing Commercial users of the product with publicity material

Commercial uptake

Conferences Scientists and commercial companies at conferences

Two conference presentations by CABI

Patent application Successful patent (through Exosect) Patent

Part E - Dissemination & Impact (2)Impact of Project(Scientific, Technical, Commercial, Social, Environmental)

Impact Target Measures

Scientific and Technical. Replacement of chemical insecticides in grain stores with IPM strategies using mycoinsecticides as central technique. Enhanced knowledge of mycoinsecticides for CABI ; this generic information will benefit the development of any Beauveria mycoinsecticide against any pest.

Commercial uptake. Control success

Commercial. Viable commercial product enabling stores to control pests

Sales, percentage of suitable stores using product

Social. Livelihoods of producers, storers and processers protected; supplies of goods protected for consumers.

Uptake of product. Acceptability of processed good by consumers.

Environmental. Chemical insecticides phased out.

Chemical pesticide use data

Part F – Reporting and Sign-off (1)Reporting

Information Provider Information Required Interested Parties Frequency

a) Project executive

b)

c)

a) PID

b)

c)

Corporate Management (CABI)

a) Once

b)

c)

a) Project Manager

b)

c)

a) Highlight Reports

b) End Project Report

c)

Project Board (CABI)

a) As requested

b) End of project

c)

a) Project Manager

b)

c)

a) Highlight Reports

b)

c)

Marketing (CABI) a) As identified by Project Manager or Board

b)

c)

a)Project Manager

b)

c)

a) Progress Report

b)

c)

Collaborators a) 6 Monthly

b)

c)

a) Project Manager

b)

c)

a) Progress Report

b)

c)

Partners (External) a) 6 monthly

b)

c)

a) Project Manager

b)

c)

a) Annual Progress Reports

b) Financial Report

c)

Donors / Funding Agency (External)

a) As specified by donor

b)

c)

a)

b)

a)

b)

Other – please specify

a)

b)

Part F – Reporting & Sign-off (2)Supporting Documentation

As a minimum to accompany the completed PID:● Project Financial Analysis

Extra supporting documentation may be provided:● Gantt Chart (or Log Frame)● Any other documentation as appropriate

Please note that projects with an Intellectual Property Right (IPR) component require the contract to be submitted to PMG prior to signature.

Part F – Reporting & Sign-off (3)Authorisation

Project Executive / EMT: ……………………………………………

Date: …………………………………………………………..

PMG Sign-off (Level 1 Projects) …………………………………………..

Date: ………………………………………………………………………….

Approval of: PID Development of Business Plan

PMG Comments and/or Follow-on Actions:

Appendix A – New Product / Initiative (1)

Customer Needs & Trends

What Problem Are We Trying to Solve?

Chemical > insecticides being phased out with no suitable alternative for control.

Purchasing Criteria

Purchasing Process

Preferred Pricing Models

Strategic Fit

Market Attractiveness

Small but needy; no alternatives available. Markets beyond stored grain, both product wise and geographical.

Market Growth & Trends

Biopesticides taking larger share of market generally; this product will help to accelerate trend.

Profitability Good but small from stored grain market. Significantly larger markets if including other stored products. Help with all other Beauveria based products whatever the target

Competition None at present for storage product.

Appendix A – New Product / Initiative (2)

Financial Impact

Revenue Opportunity <£ revenue likely to be limited for UK sales (low £10ks after 5 years). Spin-offs would be larger markets

Total Investment Required

<Nil, except proposal development

Return on Investment <>

Proposed Product / Initiative Specifications

Product / Initiative Scope <Mycoinsecticide to use in stores to control storage pests. Effective pest control without using chemical insecticides. No more costly. Available – most chemicals are being phased out; no other mycoinsecticide being developed for this market

Workflow Integration <Applied at usual treatment time, using existing eqipment, hence compatible without major changes by user.

Revenue Model <Royalty on sales, to be negotiated

Sales & Marketing Strategy

<Responsibility of commercial partners.

Technology Strategy <Funded by Technology Strategy Board